How do people taking psychiatric drugs explain their "Chemical Imbalance?"

Ethical Human Psychology and Psychiatry

Volumn 13, Issue 3, 2011, Pages 176-189

  Cohen, David ^a   Hughes, Shannon ^b  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b UTAH STATE UNIVERSITY   (United States)

Author keywords

Chemical imbalance; Illness and healing narratives; Informal reasoning; Psychoactive drugs

Indexed keywords

ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CENTRAL STIMULANT AGENT; LITHIUM; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ANTICONVULSANT THERAPY; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BORDERLINE STATE; CHEMICAL IMBALANCE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DEPRESSION; DISTRESS SYNDROME; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; HEALING; HEALTH BELIEF; HUMAN; MALE; MEDICAL HISTORY; MENTAL DISEASE; MENTAL HEALTH CARE PERSONNEL; POST HOC ANALYSIS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOLOGY; PSYCHOPHARMACOLOGY; REINFORCEMENT; SEMI STRUCTURED INTERVIEW;

EID: 84870981503     PISSN: 15594343     EISSN: 19389000     Source Type: Journal    
DOI: 10.1891/1559-4343.13.3.176     Document Type: Article

References (33)

1. Aikens, J. E., Nease, D. E., Jr., & Klinkman, M. S. (2008). Explaining patients' beliefs about the necessity and harmfulness of antidepressants. Annals of Family Medicine, 6(1), 23-29.
2. American Psychiatric Association. (2003, September 25). Statement on diagnosis and treatment of mental disorders (Release no. 03-39). Retrieved January 6, 2010, from http://www.psych.org/news_room/press_releases/mentaldisorders0339.pdf
3. American Psychiatric Association. (2005, May 4). Mental illness stigmas are receding, but misconceptions remain (Release no. 05-24). Retrieved January 6, 2010, from http://www.psych.org/news_room/press_releases/05-24APANewsReleaseonPoll-%20final.pdf
4. Belmaker, R. H., & Agam, G. (2008). Major depressive disorder. New England Journal of Medicine, 358(1), 55-68.
5. Bury, M. (2001). Illness narratives: Fact or fiction? Sociology of Health and Illness, 23(3), 263-285.
6. Cohen D. (2003). The psychiatric medication history: Context, meaning, and purpose. Social Work in Mental Health, 1(4), 5-28.
7. Deacon, B. J., & Baird, G. L. (2009). The chemical imbalance explanation of depression: Reducing blame at what cost? Journal of Clinical and Social Psychology, 28(4), 415-435.
8. Danco, J. C. (2008). Why psychiatric drugs "work": The attribution of positive effects due to psychological factors. Ethical Human Psychology and Psychiatry, 10(1), 10-15.
9. Fekete, D. J. (2004). How I quit being a "mental patient" and became a whole person with a neurochemical imbalance: Conceptual and functional recovery from a psychotic episode. Psychiatric Rehabilitation Bulletin, 28(2), 189-194.
10. France, C. M., Lysaker, P. H., & Robinson, R. P. (2007). The "chemical imbalance" explanation for depression: Origins, lay endorsement, and clinical implications. Professional Psychology: Research & Practice, 38(4), 411-420.
11. Garcia, J. E. (2005). Letter to the editor. The Family Journal, 13(2), 129.
12. Gomory, T., Wong, S., Cohen, D., & Lacasse, J. (2011). Clinical social work and the biomedical industrial complex. Journal of Sociology and Social Welfare, 28(4), 135-165.
13. Hughes, S., & Cohen, D. (2011). Can online consumers contribute to drug knowledge? A mixedmethods comparison of consumer-generated and professionally controlled psychotropic medication information on the internet. Journal of Medical Internet Research, 13(3), e53.
14. Insel, T. R. (2010, February 19). A decade after the decade of the brain: Understanding mental disorders as circuit disorders. Cerebrum. Retrieved June 19, 2011, from http://www.dana.org/news/ cerebrum/detail.aspx?id=25802
15. Jacobs, D., & Cohen, D. (1999). What is really known about psychological alterations produced by psychiatric drugs? International Journal of Risk and Safety in Medicine, 12(1), 37-47.
16. Johnson, M. R., Gold, P. B., Siemion, L., Magruder, K. M., Frueh, B. C., & Santos, A. B. (2000). Panic disorder in primary care: Patients' attributions of illness causes and willingness to accept psychiatric treatment. International Journal of Psychiatry in Medicine, 30(4), 367-384.
17. Karp, D. A. (2006). Is it me or my meds? Living with antidepressants. Cambridge, MA: Harvard University Press.
18. Leo, J., & Lacasse, J. R. (2008). The media and the chemical imbalance theory of depression. Society, 45(1), 35-45.
19. Leykin, Y., Amsterdam, J. D., DeRubeis, R. J., Gallop, R., Shelton, R. C., & Hollon, S. D. (2007). Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. Journal of Consulting and Clinical Psychology, 75, 267-276.
20. Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., et al. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. The New England Journal of Medicine, 353(12), 1209-1223.
21. Malhi, G. S., Parker, G. B., & Greenwood, J. (2005). Structural and functional models of depression: From sub-types to substrates. Acta Psychiatrica Scandinavica, 111(2), 94-105.
22. Manber, R., Chambers, A. S., Hitt, S. K., McGahuey, C., Delgado, P., & Allen, J. J. (2003). Patients' perception of their depressive illness. Journal of Psychiatric Research, 37(4), 335-343.
23. Moncrieff, J., & Cohen, D. (2009). How do psychiatric drugs work? British Medical Journal, 338, b1963.
24. Olsen, D. P. (2000). Policy implications of the biological model of mental disorder. Nursing Ethics, 7(5), 412-424.
25. Payton, A. R., & Thoits, P. A. (2011). Medicalization, direct-to-consumer-advertising, and mental illness stigma. Society and Mental Health, 1(1), 55-70.
26. Perlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., et al. (2006). Predictors of recurrence in bipolar disorder: Primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). The American Journal of Psychiatry, 163(2), 217-224.
27. Phelan, J. C. (2005). Geneticization of deviant behavior and consequences for stigma: The case of mental illness. Journal of Health and Social Behavior, 46(4), 307-322.
28. Ridge, D., & Ziebland, S. 2006 "The old me could never have done that": How people give meaning to recovery following depression. Qualitative Health Research, 16(8), 1038-1053.
29. Schnittker, J., Freese, J., & Powell, B. (2000). Nature, nurture, neither nor: Black-white differences in beliefs about the causes and appropriate treatment of mental illness. Social Forces, 78, 1101-1132.
30. Stone, M. B., & Jones, M. L. (2006). Clinical review: Relationship between antidepressant drugs and suicidality in adults. Bethesda, MD: Food and Drug Administration. Retrieved February 16, 2008, from http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf
31. Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., et al. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR&z.ast;D: Implications for clinical practice. The American Journal of Psychiatry, 163(1), 28-40.
32. Walton, D. N. (1996). Argumentation schemes for presumptive reasoning. Mahwah, NJ: Lawrence Erlbaum Associates.
33. Zinberg, N. E. (1984). Drug, set, and setting: The basis for controlled intoxicant use. New Haven, CT: Yale University Press.